Glaukos Glaukos is an ophthalmic medical technology and pharmaceutical company that develops therapies for treating glaucoma, corneal disorders, and retinal diseases. | ARTIVION CryoLife is a company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures focused on aortic repair. | ||||
Founding Date | Founding Date 1998 | Founding Date 1971 | Founding Date 1984 | Founding Date 2015 | Founding Date 1985 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Aliso Viejo, US HQ Buenos Aires, AR Heatherton, AU Sao Paulo, BR Richmond Hill, CA San José, CR Wiesbaden, DE see more | Locations Kennesaw, US HQ Paris, FR Singapore, SG Guildford, GB Austin, US | Locations London, GB HQ Dandenong South, AU Wien, AT Markham, CA Bogotá, CO Helsinki, FI Helsinki, FI see more | Locations Gainesville, US HQ Castle Hill, AU Mérignac, FR Meylan, FR Kiel, DE Brescia, IT Tokyo, JP see more | |
Employees | Employees 90716% increase | Employees 3,65721% increase | Employees 1,2009% increase | Employees 2,900 | Employees 989 |
Valuation ($) | Valuation ($) 7.6 b | Valuation ($) 3.7 b | Valuation ($) 1.1 b | Valuation ($) 2.9 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $314.7m (FY, 2023) | Revenue (est.) $1.3b (FY, 2024) | Revenue (est.) $354m (FY, 2023) | Revenue (est.) $1.2b (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods $75.6m (FY, 2023) | Cost of goods $617.5m (FY, 2024) | Cost of goods $124.8m (FY, 2023) | Cost of goods $382.3m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit $239.1m (FY, 2023) | Gross profit $691.5m (FY, 2024) | Gross profit $229.2m (FY, 2023) | Gross profit $771.3m (FY, 2023) | Gross profit N/A |
Net income | Net income ($134.7m) (FY, 2023) | Net income $117.6m (FY, 2024) | Net income ($30.7m) (FY, 2023) | Net income $17.5m (FY, 2023) | Net income N/A |
Operating ⚠ | |||||
Facility Space Leased, sq. ft. | Facility Space Leased, sq. ft. 318 k (FY, 2022) | Facility Space Leased, sq. ft. 885.4 k (FY, 2023) | Facility Space Leased, sq. ft. N/A | Facility Space Leased, sq. ft. N/A | Facility Space Leased, sq. ft. N/A |
Funding | |||||
Total funding raised | Total funding raised $ 115m | Total funding raised N/A | Total funding raised $ 1.3m | Total funding raised N/A | Total funding raised N/A |